Precision oncology across the ages: Impact on children, adolescents, and young adults

Vivek Subbiah; Razelle Kurzrock

doi:10.1016/j.ccell.2024.08.010

Precision oncology across the ages: Impact on children, adolescents, and young adults

Cancer Cell. 2024 Sep 9;42(9):1473-1479. doi: 10.1016/j.ccell.2024.08.010. Epub 2024 Aug 29.

Authors

Vivek Subbiah¹, Razelle Kurzrock²

Affiliations

¹ Early-Phase Drug Development, Sarah Cannon Research Institute, Nashville, TN, USA. Electronic address: vivek.subbiah@scri.com.
² Genomic Sciences and Precision Medicine Center, and Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA; Chief Medical Officer, Equal Opportunity and Diversity Office, WIN Consortium, Paris, France; Medical Oncology, University of Nebraska, Omaha, NE, USA.

PMID: 39214098
DOI: 10.1016/j.ccell.2024.08.010

Abstract

Precision oncology endeavors to tailor therapies based on individual patient and tumor characteristics. This rapidly evolving field has transformed cancer treatment across all age groups. In this commentary, we review the application of precision oncology across different age groups, specifically in children, adolescents, and young adults, and emphasize that precision medicine is age and tissue agnostic.

Publication types

Review

MeSH terms

Adolescent
Age Factors
Child
Humans
Medical Oncology* / methods
Medical Oncology* / trends
Neoplasms* / genetics
Neoplasms* / therapy
Precision Medicine* / methods
Precision Medicine* / trends
Young Adult